Evaluation of drug-drug interactions for oncology therapies: in vitro-in vivo extrapolation model-based risk assessment.
about
Pharmacogenomic Characterization and Isobologram Analysis of the Combination of Ascorbic Acid and Curcumin-Two Main Metabolites of Curcuma longa-in Cancer Cells.Toward standardized reporting of drug interactions: the READI checklist for anecdotal reports.Potential risks associated with traditional herbal medicine use in cancer care: A study of Middle Eastern oncology health care professionals.
P2860
Evaluation of drug-drug interactions for oncology therapies: in vitro-in vivo extrapolation model-based risk assessment.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Evaluation of drug-drug intera ...... n model-based risk assessment.
@en
type
label
Evaluation of drug-drug intera ...... n model-based risk assessment.
@en
prefLabel
Evaluation of drug-drug intera ...... n model-based risk assessment.
@en
P2860
P356
P1476
Evaluation of drug-drug intera ...... n model-based risk assessment.
@en
P2093
Nigel J Waters
P2860
P304
P356
10.1111/BCP.12563
P407
P577
2015-06-01T00:00:00Z